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Introduction
Hypertension is the most prevalent treatable risk factor for 
cardiovascular diseases, affecting ±75% of people aged 
over 70 years.1, 2 There is controversy regarding hyperten-
sion management in older people with cognitive impair-
ment,3 despite these morbidities often coexisting in this 
group.4 This group has been excluded from randomised 
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Abstract
Background: Hypertension and cognitive impairment often coexist in older people. Office blood pressure measurement 
is a poor indicator for diagnosing hypertension in the general population. However, its diagnostic accuracy has not been 
substantially studied in patients with cognitive impairment.
Aim: The aim of this study was to determine the proportion of misdiagnosis of hypertension in patients with mild cognitive 
impairment and dementia compared to no cognitive impairment, by comparing office blood pressure measurement with 
home blood pressure measurement.
Methods: A cross-sectional study including consecutive patients visiting a memory clinic between 2014 and 2017. Home 
blood pressure was measured for one week according to the European guidelines. Office blood pressure was assessed 
during routine clinical practice. Using guideline definitions for normal blood pressure and hypertension, we investigated 
the proportion of disagreement between office blood pressure measurement and home blood pressure measurement. 
Univariable and multivariable logistic regression compared disagreement in diagnosis between patients with dementia, 
mild cognitive impairment and no cognitive impairment.
Results: Of 213 patients (aged 73.4±9.0 years, 42% women) 82 had dementia, 65 had mild cognitive impairment and 
66 had no cognitive impairment. Mean office blood pressure was 156/84±23/11 mmHg and mean home blood pressure 
was 139/79±16/10 mmHg. In 31% of patients, there was disagreement in hypertension diagnosis. This proportion was 
higher for mild cognitive impairment (38.5%) and dementia (35.4%) compared to no cognitive impairment (18.2%), with 
adjusted odds ratios of 3.7 (95% confidence interval 1.5–9.0), P=0.005 for mild cognitive impairment and 3.4 (1.3–8.6), 
P=0.011 for dementia.
Conclusions: In memory clinic patients with dementia and mild cognitive impairment, the diagnostic accuracy of office 
blood pressure measurement is lower compared to patients without cognitive impairment. To avoid the risk of making 
improper treatment decisions in this vulnerable group, a diagnosis of hypertension should be based on home blood 
pressure measurement, not office blood pressure measurement.
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controlled trials estimating the benefit-to-risk ratio of anti-
hypertensive treatment. Based on observational evidence, 
it is postulated that people with cognitive impairment are 
more prone to side-effects of treatment (such as hypoten-
sion and falls) and might even show a more rapid cognitive 
decline with hypertension treatment.5, 6 Considering this 
ongoing discussion, the current clinical advice is to assess 
blood pressure (BP) carefully and accurately in this group,7 
because treatment decisions based on an incorrect diagno-
sis of hypertension may expose people with cognitive 
impairment to greater risks than older people with normal 
cognitive function.
It has generally been acknowledged that the accuracy of 
an office blood pressure measurement (OBPM) is low and 
hence out-of-office measurements are now recommended 
by guidelines.8, 9 Ambulatory blood pressure monitoring 
over 24 hours (ABPM) has been accepted internationally 
as the gold standard for hypertension diagnosis,10 but can 
be experienced as invasive,11 and may result in lifestyle 
disruption, especially in people with cognitive impair-
ment, which reduces its representability for daily life. In 
addition, it comes with considerable costs. Home blood 
pressure monitoring (HBPM) has been shown to be a fea-
sible and reliable alternative for ABPM in several popula-
tions,12 including patients with dementia.13 Not 
unexpectedly, the majority of dementia patients also indi-
cated that they preferred HBPM over ABPM.
In a general older population (mean age 70 years) the 
prevalence of a misdiagnosis of hypertension with OBPM, 
compared with HBPM, was 22%.14 This percentage con-
sisted of false positives (i.e. white-coat hypertension, 13%) 
and false negatives (i.e. masked hypertension, 9%). It is 
unknown whether these findings can be extrapolated to a 
population of older people with cognitive impairment. 
Therefore, the aim of this study was to investigate the pro-
portion of misdiagnosis of hypertension with OBPM, 
when compared to HBPM, in older people with mild cog-
nitive impairment (MCI) and dementia.
Methods
Participants
This cross-sectional study included consecutive patients 
referred to the memory clinic at a university teaching hos-
pital between 2014 and 2017. Patients who agreed to per-
form HBPM were eligible for this study. The study was 
approved by the medical ethics committee and used an 
opt-out consent approach for the use of medical records. 
The investigation conforms with the principles outlined in 
the Declaration of Helsinki.
Of 1159 referred patients, 261 agreed to perform HBPM 
and did not opt out. Patients who received HBPM had 
higher systolic office blood pressure (SBP; 155.9±22.8 vs. 
150.9±23.4 mmHg, P=0.005), were less often women 
(40.7% vs. 53.0%, P=0.001), and less frequently had a diag-
nosis of dementia (39.5% vs. 58.8%, P<0.001). For details 
see Supplementary Table 1 and Supplementary Figure 1.
Clinical measurements
Clinical information was collected during a comprehen-
sive geriatric assessment by a geriatric medicine registrar. 
This included information on sociodemographics, psycho-
social abilities, functional abilities, cardiovascular history, 
medication use and cognitive screening. Cardiovascular 
history was marked as present if one of the following con-
ditions was identified in the medical history: chronic heart 
failure, coronary heart disease, arrhythmia, cerebrovascu-
lar disease, or peripheral artery disease. Cognitive screen-
ing included the Mini-Mental State Examination (MMSE; 
01/2014–04/2016) or the Montreal cognitive assessment 
(MoCA; 05/2016–12/2017).15, 16 Functional abilities were 
assessed with the Barthel index for activities of daily liv-
ing and the Lawton–Brody scale for instrumental activities 
of daily living.17, 18 Supine OBPM was taken using a man-
ual sphygmomanometer according to standard clinical 
practice. Cognitive diagnoses were established in a multi-
disciplinary meeting with geriatricians and neuropsychol-
ogists, based on all information from the geriatric 
assessment and when necessary after additional diagnostic 
testing (i.e. neuropsychological testing or neuro-imaging), 
using international diagnostic criteria.19, 20 Based on this 
assessment we categorised patients into three cognitive 
groups: dementia (any type), MCI and cognitively normal 
(CN; i.e. subjective cognitive complaints).
Home BP measurement
HBPM involved a validated, memory equipped, automatic 
oscillometric device (Microlife WatchBP Home, Microlife, 
Heerbrugg, Switzerland), following recommendations of 
the European Society of Hypertension.21, 22 This comprised 
duplicate measurements in the morning (06:00–10:00 
hours) and evening (17:00–21:00 hours) for 7 consecutive 
days, resulting in a maximum of 28 measurements. As rec-
ommended, measurements for day 1 were discarded and 
mean BP was not calculated if patients performed fewer 
than 12 measurements.22 Patients and (when applicable) 
their caregiver received a demonstration and written instruc-
tions on how to measure home BP. Patients were instructed 
to sit in a straight chair with the arm supported by a table for 
at least 5 minutes before starting a measurement.
Outcomes
The main outcome of interest was the presence of disa-
greement in hypertension diagnosis between OBPM and 
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HBPM. Disagreement in diagnosis was defined as either 
hypertension on OBPM, but normal HBPM (i.e. white-
coat hypertension) or as normal OBPM, but hyperten-
sion on HBPM (i.e. masked hypertension). The cut-off 
point for hypertension on OBPM was SBP ⩾140 mmHg 
and/or diastolic blood pressure (DBP) ⩾90 mmHg. The 
cut-off point for hypertension on HBPM was SBP ⩾135 
mmHg and/or DBP ⩾85 mmHg.8 To explore these 
results further, the presence of white-coat hypertension 
and masked hypertension were also analysed separately 
and an analysis with only morning or evening HBPM 
was performed.
Statistical analysis
Continuous and categorical variables were presented as 
mean (SD) or median (interquartile range) and % (n), 
respectively. Descriptive variables were compared between 
patients with dementia, MCI and CN with analysis of vari-
ance, chi-squared test or the Kruskal–Wallis test, as 
appropriate.
Univariable and multivariable logistic regression 
models were used to examine the association between 
disagreement in hypertension diagnosis and cognitive 
groups. The group of CN patients was used as a refer-
ence. In the multivariable model we adjusted for age, sex, 
level of education (low/medium/high),23 cardiovascular 
history (present/absent), use of BP-lowering medication 
(yes/no) and living situation (alone or with spouse). 
Unadjusted and adjusted odds ratios with 95% confi-
dence intervals were reported. All analyses were per-
formed using IBM SPSS Statistics 25.0 (SPSS, Inc., 
Chicago, IL, USA). In order to detect a difference in the 
proportion of misdiagnosis of 18%, with a power of 80% 
and alpha set at 0.05, a sample size of 209 patients was 
required. For details of the sample size calculation see 
the Supplementary material.
Results
Ninety per cent (236/261) of the patients who agreed to 
perform HBPM reached the minimum threshold of 12 
measurements. There were no relevant differences in char-
acteristics between those with successful and unsuccessful 
HBPM, as described in Supplementary Table 2. For 9.7% 
(23/236) of the patients OBPM was missing in the medical 
record, leading to a final study sample of 213.
Table 1 shows the characteristics of the final study sam-
ple. More than two-third (69%) of the patients in the study 
had a diagnosis of dementia or MCI. Patients with demen-
tia or MCI were significantly older compared to CN 
patients. Mean home BP was on average −16.8/–5.0 
mmHg lower than office BP. This difference was similar 
across the groups.
In 31% of patients, there was disagreement in hyperten-
sion diagnosis between OBPM and HBPM. This proportion 
was 35.4% for dementia patients, 38.5% for MCI patients 
and 18.2% for CN patients (Figure 1). The unadjusted and 
adjusted odds ratios and 95% confidence intervals are pre-
sented in Table 2. Compared to the CN patients, the adjusted 
odds ratios of disagreement in diagnosis were 3.4 (1.3–8.6) 
for dementia and 3.7 (1.5–9.0) for MCI.
In additional analyses we analysed the two types of 
disagreement in hypertension diagnosis separately. We 
observed a similar pattern for white-coat hypertension, but 
not for masked hypertension (Table 2). When morning and 
evening HBPM were analysed separately, similar results 
were obtained (Supplementary Tables 3 and 4).
Discussion
We investigated the diagnostic accuracy of OBPM com-
pared to HBPM in a memory clinic population. Using 
recommended cut-offs for hypertension diagnosis, 31% 
of patients showed disagreement between OBPM and 
HBPM. The proportion of disagreement was doubled in 
patients with dementia and MCI compared to CN patients. 
Even after adjusting for several demographic factors, we 
found that having dementia or MCI was associated with 
an increased risk of incorrect hypertension diagnosis. 
This was mainly driven by a higher prevalence of white-
coat hypertension in dementia and MCI and in a smaller 
extent to a higher prevalence of masked hypertension in 
dementia.
Previous research showed that the proportion of disa-
greement between OBPM and HBPM in a cohort of treated 
hypertensive patients (mean age 70 years) was 22%,14 
which is comparable to our observation in the CN group. 
Our results now indicate that in older people with cogni-
tive impairment, OBPM is even less accurate. Given previ-
ous observations that HBPM is well tolerated and reliable 
in patients with dementia,13 this advocates for the use of 
HBPM before any decisions regarding BP management 
are made.
Several concepts can be proposed to explain this obser-
vation. First, patients with MCI or dementia visiting the 
clinic might experience more stress or anxiety, resulting 
in a higher proportion of white-coat hypertension.24 More 
speculatively, the seemingly higher prevalence of masked 
hypertension in dementia patients might be an expression 
of reduced compliance to antihypertensive treatment in 
daily life,25 while patients are reminded to take their medi-
cation on the morning of a planned doctor’s visit. Of note 
here is that 10/12 dementia patients with masked hyper-
tension were indeed prescribed antihypertensive medica-
tion. Finally, increased BP variability has been suggested 
to be involved in the pathophysiology of dementia and 
can result in a less reliable measurement with only one 
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observation, as is the case with OBPM.26 In these inter-
pretations we refer to HBPM as the reference standard, 
which is supported by ample evidence. However, it can-
not be completely ruled out that HBPM is responsible for 
the observed disagreement between groups.
Strengths and limitations
In this study, HBPM was measured according to the 
European guidelines using a validated device equipped 
with a memory function and set at fixed time windows. 
Measurement of OBPM was part of the routine clinical 
practice, and as a result was assessed by different physi-
cians, which could have introduced observer bias.27 
Nevertheless, it does represent normal clinical practice for 
OBPM. Also, OBPM was performed manually and HBPM 
was automated. While it would have been a good exten-
sion of this work also to study automated OBPM, it was 
recently shown that only unattended automated OBPM is 
comparable to HBPM and attended automated OBPM is as 
discrepant from HBPM as manual OBPM.28
Patients who agreed to perform HBPM were biased 
towards cognitively healthier patients with a higher 
OBPM. Still, the studied sample included a large diversity 
of age, cognitive function and BP. We compared our 
dementia and MCI patients to memory clinic patients with-
out objectively diagnosed cognitive impairment and not to 
a group of healthy controls. The generalisability of this 
Table 1. Descriptive characteristics of memory clinic patients by cognitive group.
Total sample 
(n=213)
Dementia  
(n=82)
MCI
(n=65)
CN
(n=66)
P value
Characteristics
Age, years 73.4 (9.0) 77.3 (7.4) 74.4 (8.0) 67.5 (8.8) <0.001
Sex, female, % (n) 41.8 (89) 45.1 (37) 43.1 (28) 36.4 (24) 0.544
MMSE score, median (IQR)a 23 (26–28) 23 (20–25) 26 (24–28) 28 (26–29) <0.001
MoCA score, median (IQR)a 21 (17–24) 16.5 (11–21) 22 (19–24) 25 (21–28) <0.001
ADL, median (IQR)b 20 (19–20) 20 (18–20) 20 (19–20) 20 (19–20) 0.042
IADL, median (IQR)c 6.0 (3.5–8.0) 4.0 (2.0–6.0) 7.0 (5.5–8.0) 8.0 (4.3–8.) <0.001
Number of drugs, median (IQR) 4 (1–7) 4 (2–7) 4 (1–7) 5 (1–8) 0.872
Use of BP-lowering drug, % (n) 58.2 (124) 61.0 (50) 56.9 (37) 56.1 (37) 0.808
History of CVD, % (n) 43.2 (92) 46.3 (38) 43.1 (28) 39.4 (26) 0.698
Education level, % (n)d 0.149
 Low 15.5 (33) 22.0 (18) 12.3 (8) 10.6 (7)  
 Medium 50.2 (107) 52.4 (43) 49.2 (32) 48.5 (32)  
 High 34.3 (73) 25.6 (21) 38.5 (25) 40.9 (27)  
Living with spouse, % (n) 73.7 (157) 74.4 (61) 76.9 (50) 69.7 (46) 0.633
Blood pressure measurements
Office systolic BP, mmHg 156.1 (23.3) 157.5 (26.9) 156.6 (18.8) 154.0 (22.6) 0.650
Office diastolic BP, mmHg 83.9 (10.6) 82.6 (10.2) 83.1 (9.0) 86.4 (12.1) 0.075
Office heart rate, bpme 67.8 (11.5) 68.6 (12.2) 68.8 (11.7) 65.9 (10.2) 0.313
Home systolic BP, mmHg 139.3 (16.2) 140.7 (16.4) 138.1 (16.4) 138.8 (15.9) 0.596
Home diastolic BP, mmHg 78.9 (9.5) 77.0 (9.2) 78.0 (9.5) 82.1 (9.1) 0.003
Home heart rate, bpm 69.2 (9.8) 69.3 (10.6) 69.6 (9.8) 68.6 (8.8) 0.819
Home office systolic BP, mmHg −16.8 (21.1) −16.8 (24.4) −18.5 (20.8) −15.2 (17.9) 0.685
Home office diastolic BP, mmHg −5.0 (10.4) −5.6 (10.4) −5.1 (9.6) −4.3 (11.2) 0.734
Study outcomes
Disagreement in diagnosis, % (n) 31.0 (66) 35.4 (29) 38.5 (25) 18.2 (12)  
White-coat hypertension, % (n) 22.5 (48) 20.7 (17) 33.8 (22) 13.6 (9)  
Masked hypertension, % (n) 8.5 (18) 14.6 (12) 4.6 (3) 4.5 (3)  
aRanges from 0 to 30, higher score indicates better cognitive performance. MMSE was used at the memory clinic between 01/2014 and 04/2014 and 
is available for 156 patients, while MoCA was used between 05/2016 and 12/2017 and is available for 52 patients.
bRanges from 0 to 20, higher score indicate less ADL dependency. Score is available for 171 patients.
cRanges from 0 to 8, higher score indicates less IADL dependency. Score is available for 169 patients.
dClassified according to a previous reported system [27].
eAvailable for 176 patients.
Results are presented as mean (standard deviation) unless otherwise noted. P value derived from analysis of variance, chi-squared test or Kruskal–
Wallis test, as appropriate.
MCI: mild cognitive impairment; CN: cognitively normal; IQR: interquartile range; MMSE: Mini-Mental State Examination; MoCA: Montreal cognitive 
assessment; ADL: activities of daily living; IADL: instrumental activities of daily living; BP: blood pressure; CVD: cardiovascular disease.
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group has been questioned,29 although it was recently 
shown that cognitive function in this group is mostly stable 
in the long term.30 In addition, the proportion of misdiag-
nosis (18.5%) in our CN group compares well with the 
22% observed in the general population of older people. 
As the study had a cross-sectional study design, we were 
not able to study the prognostic value of HBPM compared 
to OBPM. Finally, despite giving oral and written instruc-
tions not to measure within one hour after food or drug 
intake and to have 5 minutes rest before measuring, we 
cannot ensure adherence to these instructions.
Conclusion
We found that in memory clinic patients with dementia 
and MCI the proportion of disagreement between OBPM 
and HBPM was high, indicating a lower diagnostic accu-
racy of OBPM compared to older memory clinic patients 
with no cognitive impairment. For clinical practice, this 
advocates the use of HBPM in this group before any deci-
sions regarding BP management are made. In view of the 
new guideline advice for lower thresholds for treatment of 
hypertension in older patients, a diagnosis of hypertension 
should be based on reliable BP measurements. For one-
third of patients with MCI and dementia, OBPM leads to 
an inaccurate diagnosis. In these patients, the benefit-to-
risk ratio of hypertension treatment remains uncertain and 
an individualised approach based on accurate BP measure-
ments is therefore highly desirable.
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Figure 1. Proportion of disagreement in hypertension 
diagnosis by cognitive group, split in proportion due to white-
coat hypertension and due to masked hypertension.
Disagreement in diagnosis was defined as high office blood pressure 
(OBP), but a normal home blood pressure (HBP) (white-coat hy-
pertension) or as normal OBP, but high HBP (masked hypertension) 
with cut-off points for high OBP of systolic blood pressure (SBP) 
⩾140 mmHg and/or diastolic blood pressure (DBP) ⩾90 mmHg and 
cut-off points for high HBP of SBP ⩾135 mmHg and/or DBP ⩾85 
mmHg. CN: cognitively normal; MCI: mild cognitive impairment; HT: 
hypertension.
Table 2. Univariable and multivariable logistic regression models.
Disagreement in HT diagnosis White-coat hypertension Masked hypertension
 OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Unadjusted
CN 1.0 (ref) − 1.0 (ref) − 1.0 (ref) −
MCI 2.8 (1.3–6.3) 0.011 3.2 (1.4–7.7) 0.008 1.0 (0.2–5.3) 0.985
Dementia 2.5 (1.2–5.3) 0.022 1.7 (0.7–4.0) 0.263 3.6 (1.0–13.3) 0.055
Adjusted
CN 1.0 (ref) − 1.0 (ref) − 1.0 (ref) −
MCI 3.7 (1.5–9.0) 0.005 5.1 (1.9–13.9) 0.001 0.7 (0.1–4.4) 0.747
Dementia 3.4 (1.3–8.6) 0.011 2.9 (1.0–8.5) 0.047 2.3 (0.5–10.6) 0.295
The adjusted model is corrected for age, sex, educational level, use of blood pressure-lowering medication, history of cardiovascular history and 
living situation.
HT: hypertension; OR: odds ratio; CI: confidence interval; CN: cognitively normal; MCI: mild cognitive impairment.
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